2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg M. Bajema, John Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni, Frédéric Houssiau, David Jayne, Marios Kouloumas, Annegret Kuhn, J.L. Larsen, Kirsten Lerstrøm, Gabriella Moroni, Marta Mosca, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Vladimı́r Tesař, Anǵela Tincani, Anne Troldborg, Ronald van Vollenhoven, Joerg Wenzel, George Βertsias, Dimitrios T. Boumpas
Topics & Concepts
MedicineBelimumabHydroxychloroquineRituximabAzathioprineIntensive care medicineAntiphospholipid syndromeSystemic lupus erythematosusExpert opinionPrednisoneDiseaseTocilizumabImmunologyInternal medicineInfectious disease (medical specialty)AntibodyB-cell activating factorCoronavirus disease 2019 (COVID-19)B cellSystemic Lupus Erythematosus ResearchCytokine Signaling Pathways and InteractionsAutoimmune and Inflammatory Disorders Research